NCT01855074 An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders Status COMPLETED Phase PHASE4
NCT01854944 PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT01852331 Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT01851603 Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects Status TERMINATED Phase PHASE1
NCT01850953 Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia Status COMPLETED Phase PHASE4
NCT01834638 Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680) Status TERMINATED Phase PHASE2
NCT01832766 The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes Status TERMINATED Phase PHASE1/PHASE2
NCT01831986 Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders Status UNKNOWN Phase NA
NCT01829048 A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT01828931 Lifestyle Intervention for Diabetes and Weight Management in Psychosis Status COMPLETED Phase NA
NCT01822418 Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) Status COMPLETED Phase PHASE4
NCT01819818 A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients Status COMPLETED Phase N/A
NCT01813955 Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia Status TERMINATED Phase EARLY_PHASE1
NCT01812642 A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia Status COMPLETED Phase PHASE2